Magellan Health Insights
  • Home
  • About
  • Resources
  • Voices
  • Contact

Nearly half of patients who stop taking opioids for six months resume use later

by Magellan Health Insights August 21, 2017Addiction, Behavioral Health

A study by a team of Magellan researchers, demonstrating the pervasiveness of opioid addiction, was presented at the American Psychiatric Association (APA) Annual Meeting, and was also the subject of an article by Clinical Psychiatry News.

The study, an analysis of medical and pharmacy data from 2009—2012 for 2.5 million people aged 20-64 who were part of a commercial health plan, showed that 48 percent of patients who had stopped using opioids for at least six months went on to use them again.

Dr. Shareh Ghani, vice president medical director at Magellan HealthcareDr. Shareh Ghani, vice president medical director at Magellan Healthcare, and lead author of the study spoke of the importance of fully understanding the scope of the addiction crisis: “Having worked in commercial and Medicaid markets, I have reviewed numerous cases of accidental overdose and suicides related to pain prescriptions. The opioid crisis in this country demands that we understand the issue and identify predictors of risk.”

Study co-author Gowri Shetty, vice president of analytics, underscored the importance of the work: “This study helped us understand the clinical characteristics associated with long-term and persistent opioid use and provided a better understanding of how to tailor interventions targeting those at increased risk of inappropriate opioid use.”

The opioid crisis remains a key area of research and development across Magellan Health. You can read the article by clicking here to visit the Clinical Psychiatry News website.

Share on FacebookShare on TwitterShare on Linkedin
Tags: Addiction, addiction crisis, American Psychiatric Association, APA, Clinical Psychiatry News, Dr. Shareh Ghani, Gowry Shetti, Magellan, Magellan Health, Magellan Healthcare, Opiate, Opiates, Opioid, Opioid Study
Magellan Health Insights
Previous post Magellan’s Collaboration with Click Therapeutics Expanded to Develop FDA-Cleared Therapeutic Apps Next post Magellan RX Management Hosts 14th Annual Specialty Summit

Related Articles

Specialty-Summit

2019 Specialty Summit tackles trends, emerging therapies, tech-based disruption and more

by Magellan Health Insights
September 10, 2019
TR_Blog-Header

Top 10 Takeaways: 2019 Medical Pharmacy Trend Report

by Kristen Reimers
April 21, 2020
Grief and Loss

Loss and Grief during the Pandemic

by Steven E. Pratt, MD
January 12, 2021

2 comments. Leave new

Study: Nearly Half Of Patients Who Stop Taking Opioids For Six Months Resume Use Later « CBS Philly
September 21, 2017 7:20 AM

[…] According to researchers at Magellan Health Services in San Francisco, over 50% of patients who quit opioids for six months will resume use sometime thereafter. A significant number of patients pick up the habit with prescription drugs. […]

Reply
Magellan in the News: Opioid Study
September 26, 2017 6:15 PM

[…] You can read more about the study by clicking here. […]

Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Magellan Health Logo

To learn more about how Magellan can support your organization, please visit MagellanHealth.com.

Topic suggestions or questions?
Send us your ideas at

Connect with us:

Trending Topics

  • A Present Day Look at PTSD
  • Medicine Cabinet Minefield: How old prescriptions drugs are fueling an opioid addiction crisis
  • The Trends and Complexities of Provider-Administered Drugs

Categories

Stay in the Know

Get the latest news and trending insights sent straight to your inbox.


HomeAboutResourcesVoicesContact
© 1999-2016 Magellan Health, Inc. All Rights Reserved.